# Mativ Holdings, Inc.: financial statements, quarterly MATV · NYSE · CIK 1000623 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/matv.md) · [Financials](/companies/matv/financials.md) · [Filings](/companies/matv/filings.md) · [Insiders](/companies/matv/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/matv/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [498](/filings/0001000623-24-000047.md) | [452 d](/filings/0001000623-26-000016.md) | [500](/filings/0001000623-25-000024.md) | [524](/filings/0001000623-25-000049.md) | [499](/filings/0001000623-25-000064.md) | [459 d](/filings/0001000623-26-000016.md) | [485](/filings/0001000623-26-000049.md) | [525](/filings/0001000623-26-000067.md) | [514](/filings/0001000623-25-000064.md) | [463 d](/filings/0001000623-26-000016.md) | [480](/filings/0001000623-26-000049.md) | [532](/filings/0001000623-26-000067.md) | | Cost of revenue | $m | [412](/filings/0001000623-24-000047.md) | [366 d](/filings/0001000623-26-000016.md) | [416](/filings/0001000623-25-000024.md) | [415](/filings/0001000623-25-000049.md) | [405](/filings/0001000623-25-000064.md) | [381 d](/filings/0001000623-26-000016.md) | [412](/filings/0001000623-26-000049.md) | [422](/filings/0001000623-26-000067.md) | [414](/filings/0001000623-25-000064.md) | [376 d](/filings/0001000623-26-000016.md) | [395](/filings/0001000623-26-000049.md) | [419](/filings/0001000623-26-000067.md) | | Gross profit | $m | [86.7](/filings/0001000623-24-000047.md) | [85.9 d](/filings/0001000623-26-000016.md) | [84.0](/filings/0001000623-25-000024.md) | [109](/filings/0001000623-25-000049.md) | [93.6](/filings/0001000623-25-000064.md) | [77.6 d](/filings/0001000623-26-000016.md) | [72.6](/filings/0001000623-26-000049.md) | [104](/filings/0001000623-26-000067.md) | [99.4](/filings/0001000623-25-000064.md) | [87.2 d](/filings/0001000623-26-000016.md) | [84.9](/filings/0001000623-26-000049.md) | [113](/filings/0001000623-26-000067.md) | | Research and development | $m | [5.4](/filings/0001000623-24-000047.md) | [4.6 d](/filings/0001000623-26-000016.md) | [6.0](/filings/0001000623-25-000024.md) | [5.8](/filings/0001000623-25-000049.md) | [5.7](/filings/0001000623-25-000064.md) | [5.5 d](/filings/0001000623-26-000016.md) | [6.3](/filings/0001000623-26-000049.md) | [6.7](/filings/0001000623-26-000067.md) | [5.6](/filings/0001000623-25-000064.md) | [5.0 d](/filings/0001000623-26-000016.md) | [5.5](/filings/0001000623-26-000049.md) | [4.9](/filings/0001000623-26-000067.md) | | Selling, general and administrative | $m | not reported | not reported | [61.6](/filings/0001000623-25-000024.md) | [65.1](/filings/0001000623-25-000049.md) | [54.3](/filings/0001000623-25-000064.md) | [52.8 d](/filings/0001000623-26-000016.md) | [63.3](/filings/0001000623-26-000049.md) | [57.2](/filings/0001000623-26-000067.md) | [53.7](/filings/0001000623-25-000064.md) | [54.5 d](/filings/0001000623-26-000016.md) | [54.8](/filings/0001000623-26-000049.md) | [56.6](/filings/0001000623-26-000067.md) | | Operating income | $m | [(420)](/filings/0001000623-24-000047.md) | [(2.2) d](/filings/0001000623-26-000016.md) | [(13.8)](/filings/0001000623-25-000024.md) | [10.5](/filings/0001000623-25-000049.md) | [7.0](/filings/0001000623-25-000064.md) | [2.6 d](/filings/0001000623-26-000016.md) | [(431)](/filings/0001000623-26-000049.md) | [20.1](/filings/0001000623-26-000067.md) | [16.0](/filings/0001000623-25-000064.md) | [10.1 d](/filings/0001000623-26-000016.md) | [7.3](/filings/0001000623-26-000049.md) | [35.3](/filings/0001000623-26-000067.md) | | Interest expense | $m | [16.8](/filings/0001000623-23-000062.md) | [13.4 d](/filings/0001000623-24-000009.md) | [18.3](/filings/0001000623-24-000020.md) | [18.4](/filings/0001000623-25-000049.md) | [18.3](/filings/0001000623-25-000064.md) | [19.7 d](/filings/0001000623-26-000016.md) | [17.8](/filings/0001000623-26-000049.md) | [18.6](/filings/0001000623-26-000067.md) | [17.7](/filings/0001000623-25-000064.md) | [17.0 d](/filings/0001000623-26-000016.md) | [17.5](/filings/0001000623-26-000049.md) | [19.3](/filings/0001000623-26-000067.md) | | Income tax | $m | [27.3](/filings/0001000623-24-000047.md) | [(3.2) d](/filings/0001000623-26-000016.md) | [(2.4)](/filings/0001000623-25-000024.md) | [(7.6)](/filings/0001000623-25-000049.md) | [(3.2)](/filings/0001000623-25-000064.md) | [(17.0) d](/filings/0001000623-26-000016.md) | [(24.7)](/filings/0001000623-26-000049.md) | [12.5](/filings/0001000623-26-000067.md) | [(2.4)](/filings/0001000623-25-000064.md) | [(111) d](/filings/0001000623-26-000016.md) | [3.0](/filings/0001000623-26-000049.md) | [3.2](/filings/0001000623-26-000067.md) | | Net income | $m | [(455)](/filings/0001000623-24-000047.md) | [158 d](/filings/0001000623-26-000016.md) | [(28.0)](/filings/0001000623-25-000024.md) | [(1.4)](/filings/0001000623-25-000049.md) | [(20.8)](/filings/0001000623-25-000064.md) | [1.5 d](/filings/0001000623-26-000016.md) | [(426)](/filings/0001000623-26-000049.md) | [(9.5)](/filings/0001000623-26-000067.md) | [(3.2)](/filings/0001000623-25-000064.md) | [101 d](/filings/0001000623-26-000016.md) | [(11.7)](/filings/0001000623-26-000049.md) | [3.6](/filings/0001000623-26-000067.md) | | Diluted EPS | $ per share | [(8.33)](/filings/0001000623-24-000047.md) | not reported | [(0.52)](/filings/0001000623-25-000024.md) | [(0.03)](/filings/0001000623-25-000049.md) | [(0.38)](/filings/0001000623-25-000064.md) | not reported | [(7.82)](/filings/0001000623-26-000049.md) | [(0.18)](/filings/0001000623-26-000067.md) | [(0.06)](/filings/0001000623-25-000064.md) | not reported | [(0.22)](/filings/0001000623-26-000049.md) | [0.06](/filings/0001000623-26-000067.md) | | Basic EPS | $ per share | [(8.33)](/filings/0001000623-24-000047.md) | not reported | [(0.52)](/filings/0001000623-25-000024.md) | [(0.03)](/filings/0001000623-25-000049.md) | [(0.38)](/filings/0001000623-25-000064.md) | not reported | [(7.82)](/filings/0001000623-26-000049.md) | [(0.18)](/filings/0001000623-26-000067.md) | [(0.06)](/filings/0001000623-25-000064.md) | not reported | [(0.22)](/filings/0001000623-26-000049.md) | [0.06](/filings/0001000623-26-000067.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [84.7](/filings/0001000623-23-000062.md) | [120](/filings/0001000623-25-000009.md) | [129](/filings/0001000623-24-000020.md) | [133](/filings/0001000623-24-000037.md) | [162](/filings/0001000623-24-000047.md) | [94.3](/filings/0001000623-26-000016.md) | [84.0](/filings/0001000623-25-000024.md) | [95.6](/filings/0001000623-25-000049.md) | [97.1](/filings/0001000623-25-000064.md) | [84.2](/filings/0001000623-26-000067.md) | [82.3](/filings/0001000623-26-000049.md) | [66.3](/filings/0001000623-26-000067.md) | | Current assets | $m | [914](/filings/0001000623-23-000062.md) | [713](/filings/0001000623-25-000009.md) | [759](/filings/0001000623-24-000020.md) | [752](/filings/0001000623-24-000037.md) | [777](/filings/0001000623-24-000047.md) | [658](/filings/0001000623-26-000016.md) | [686](/filings/0001000623-25-000024.md) | [701](/filings/0001000623-25-000049.md) | [672](/filings/0001000623-25-000064.md) | [639](/filings/0001000623-26-000067.md) | [665](/filings/0001000623-26-000049.md) | [655](/filings/0001000623-26-000067.md) | | Total assets | $m | [3,118](/filings/0001000623-23-000062.md) | [2,642](/filings/0001000623-25-000009.md) | [2,653](/filings/0001000623-24-000020.md) | [2,608](/filings/0001000623-24-000037.md) | [2,623](/filings/0001000623-24-000047.md) | [2,448](/filings/0001000623-26-000016.md) | [2,052](/filings/0001000623-25-000024.md) | [2,077](/filings/0001000623-25-000049.md) | [2,002](/filings/0001000623-25-000064.md) | [2,052](/filings/0001000623-26-000067.md) | [2,035](/filings/0001000623-26-000049.md) | [1,991](/filings/0001000623-26-000067.md) | | Current liabilities | $m | [404](/filings/0001000623-23-000062.md) | [281](/filings/0001000623-25-000009.md) | [300](/filings/0001000623-24-000020.md) | [305](/filings/0001000623-24-000037.md) | [328](/filings/0001000623-24-000047.md) | [275](/filings/0001000623-26-000016.md) | [288](/filings/0001000623-25-000024.md) | [296](/filings/0001000623-25-000049.md) | [315](/filings/0001000623-25-000064.md) | [285](/filings/0001000623-26-000067.md) | [294](/filings/0001000623-26-000049.md) | [331](/filings/0001000623-26-000067.md) | | Total liabilities | $m | [2,445](/filings/0001000623-23-000062.md) | [1,693](/filings/0001000623-25-000009.md) | [1,746](/filings/0001000623-24-000020.md) | [1,710](/filings/0001000623-24-000037.md) | [1,741](/filings/0001000623-24-000047.md) | [1,589](/filings/0001000623-26-000016.md) | [1,624](/filings/0001000623-25-000024.md) | [1,660](/filings/0001000623-25-000049.md) | [1,604](/filings/0001000623-25-000064.md) | [1,553](/filings/0001000623-26-000067.md) | [1,562](/filings/0001000623-26-000049.md) | [1,520](/filings/0001000623-26-000067.md) | | Long-term debt | $m | [1,704](/filings/0001000623-23-000062.md) | [1,102](/filings/0001000623-25-000009.md) | [1,155](/filings/0001000623-24-000020.md) | [1,134](/filings/0001000623-24-000037.md) | [1,141](/filings/0001000623-24-000047.md) | [1,087](/filings/0001000623-26-000016.md) | [1,120](/filings/0001000623-25-000024.md) | [1,088](/filings/0001000623-25-000049.md) | [1,026](/filings/0001000623-25-000064.md) | [1,015](/filings/0001000623-26-000067.md) | [1,033](/filings/0001000623-26-000049.md) | [970](/filings/0001000623-26-000067.md) | | Current portion of debt | $m | [34.5](/filings/0001000623-23-000062.md) | [2.8](/filings/0001000623-25-000009.md) | [2.7](/filings/0001000623-24-000020.md) | [2.7](/filings/0001000623-24-000037.md) | [2.8](/filings/0001000623-24-000047.md) | [2.6](/filings/0001000623-26-000016.md) | [2.7](/filings/0001000623-25-000024.md) | [2.9](/filings/0001000623-25-000049.md) | [2.9](/filings/0001000623-25-000064.md) | [2.9](/filings/0001000623-26-000067.md) | [2.9](/filings/0001000623-26-000049.md) | [4.4](/filings/0001000623-26-000067.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [673](/filings/0001000623-24-000047.md) | [949](/filings/0001000623-26-000016.md) | [907](/filings/0001000623-25-000049.md) | [898](/filings/0001000623-25-000064.md) | [882](/filings/0001000623-25-000064.md) | [859](/filings/0001000623-26-000067.md) | [428](/filings/0001000623-26-000067.md) | [417](/filings/0001000623-26-000067.md) | [397](/filings/0001000623-25-000064.md) | [499](/filings/0001000623-26-000067.md) | [472](/filings/0001000623-26-000067.md) | [471](/filings/0001000623-26-000067.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [32.9 d](/filings/0001000623-24-000047.md) | [54.2 d](/filings/0001000623-26-000016.md) | [(13.0)](/filings/0001000623-25-000024.md) | [46.1 d](/filings/0001000623-25-000049.md) | [37.6 d](/filings/0001000623-25-000064.md) | [24.1 d](/filings/0001000623-26-000016.md) | [(15.9)](/filings/0001000623-26-000049.md) | [57.6 d](/filings/0001000623-26-000067.md) | [72.8 d](/filings/0001000623-25-000064.md) | [19.3 d](/filings/0001000623-26-000016.md) | [1.0](/filings/0001000623-26-000049.md) | [67.9 d](/filings/0001000623-26-000067.md) | | Capital expenditure | $m | [14.7 d](/filings/0001000623-24-000047.md) | [16.6 d](/filings/0001000623-26-000016.md) | [12.1](/filings/0001000623-25-000024.md) | [8.7 d](/filings/0001000623-25-000049.md) | [12.1 d](/filings/0001000623-25-000064.md) | [22.1 d](/filings/0001000623-26-000016.md) | [13.9](/filings/0001000623-26-000049.md) | [8.7 d](/filings/0001000623-26-000067.md) | [6.1 d](/filings/0001000623-25-000064.md) | [11.3 d](/filings/0001000623-26-000016.md) | [8.4](/filings/0001000623-26-000049.md) | [7.5 d](/filings/0001000623-26-000067.md) | | Dividends paid | $m | [5.5 d](/filings/0001000623-24-000047.md) | [5.5 d](/filings/0001000623-26-000016.md) | [5.4](/filings/0001000623-25-000024.md) | [5.4 d](/filings/0001000623-25-000049.md) | [5.4 d](/filings/0001000623-25-000064.md) | [5.4 d](/filings/0001000623-26-000016.md) | [5.5](/filings/0001000623-26-000049.md) | [5.9 d](/filings/0001000623-26-000067.md) | [5.4 d](/filings/0001000623-25-000064.md) | [5.5 d](/filings/0001000623-26-000016.md) | [5.9](/filings/0001000623-26-000049.md) | [5.6 d](/filings/0001000623-26-000067.md) | | Share repurchases | $m | [4.2 d](/filings/0001000623-24-000047.md) | [3.6 d](/filings/0001000623-24-000009.md) | [0.7](/filings/0001000623-24-000020.md) | [0.1 d](/filings/0001000623-24-000037.md) | [0.0 d](/filings/0001000623-24-000047.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [52.6](/filings/0001000623-23-000062.md) | [54.5](/filings/0001000623-24-000020.md) | [54.7](/filings/0001000623-24-000037.md) | [54.7](/filings/0001000623-24-000047.md) | [54.3](/filings/0001000623-25-000024.md) | [54.3](/filings/0001000623-25-000049.md) | [54.3](/filings/0001000623-25-000064.md) | [54.4](/filings/0001000623-26-000049.md) | [54.6](/filings/0001000623-26-000067.md) | [54.7](/filings/0001000623-25-000064.md) | [54.8](/filings/0001000623-26-000049.md) | [55.7](/filings/0001000623-26-000067.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 55,190,098 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001000623-26-000067.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.